Surgical management of subfoveal choroidal neovascular membranes in age-related macular degeneration by macular relocation: Experiences of an early-stopped randomised clinical trial (MARAN Study)

Eye

Volumn 24, Issue 2, 2010, Pages 284-289

  Joussen, A M ^a   Wong, D ^b   Walter, P ^c   Kirchhof, B ^d   Dreyhaupt, J ^e   Bauer, C ^e   Munzinger, J ^e   Unnebrink, K ^e   Freiberger, A ^e   Seibert Grafe, M ^e   Victor, N ^e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Age related macular degeneration; Macular relocation; Randomised clinical trial

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE FIXATION; HUMAN; MACULAR RELOCATION; MULTICENTER STUDY; OBSERVATION; PERFORMANCE; PHOTODYNAMIC THERAPY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; READING; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA TRANSLOCATION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 77049094199     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.107     Document Type: Article

References (21)

1. Aisenbrey S, Lafaut BA, Szurman P, Grisanti S, Luke C, Krott R et al. Macular relocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch Ophthalmol 2002; 120: 451-459. (Pubitemid 34727816)
2. Wolf S, Lappas A, Weinberger A, Kirchhof B. Macular relocation for surgical management of subfoveal choroidal neovascularizations in patients with AMD: first results. Graefes Arch Clin Exp Ophthalmol 1999; 237: 51-57.
3. O' Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556.
4. Joussen AM, Heussen FM, Joeres S, Llacer H, Prinz B, Rohrschneider K et al. Autologous relocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 2006; 142: 17-30.
5. Radner W, Willinger U, Obermayer W, Mudrich C, Velikay-Parel M, Eisenwort B. Eine neue Lesetafel zur gleichzeitigen Bestimmung von Lesevisus und Lesegeschwindigkeit. Klin Monatsbl Augenheilkd 1998; 213: 174-181.
6. Holz FG, Unnebrink K, Engenhart-Cabilic R, Bellmann C, Pritsch M, Voelcker HE, for the RAD-Study Group. Results of a prospective randomised controlled double-blind multicenter clinical trial on external beam radiation therapy for subfoveal choroidal neovascularization secondary to AMD (RAD-Study). Ophthalmology 1999; 106: 2239-2247.
7. Bellmann C, Unnebrink K, Rubin GS, Miller D, Holz FG. Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD) Study. Graefes Arch Clin Exp Ophthalmol 2003; 241: 968-974.
8. Franke GH, Esser J, Voigtländer A, Mähner N. Erste Ergebnisse zur psychometrischen Prüfung des NEI-VFQ (National Eye Institute Visual Function Questionnaire), eines psychodiagnostischen Verfahrens zur Erfassung der Lebensqualitä t bei Sehbeeinträchtigten. Z Med Psychol 1998; 7: 178-184.
9. Mangione CM. The National Eye Institute 25-item Visual Function, Questionnaire (VFQ-25)FScoring algorithm. 2000; 1-15.
10. Toth CA, Lapolice DJ, Banks AD, Stinnett SS. Improvement in near visual function after macular relocation surgery with 360-degree peripheral retinectomy. Graefes Arch Clin Exp Ophthalmol 2004; 242: 541-548.
11. Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P et al. Full macular relocation vs photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch Clin Exp Ophthalmol 2007; 245: 1085-1095. (Pubitemid 47034332)
12. Luke M, Ziemssen F, Bartz-Schmidt KU, Gelisken F. Quality of life in a prospective, randomised pilot-trial of photodynamic therapy vs full macular relocation in treatment of neovascular age-related macular degenerationFa report of 1 year results. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1831-1836. (Pubitemid 350154018)
13. Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 2005; 112: 152-158.
14. Park CH, Toth CA. Macular relocation surgery with 360-degree peripheral retinectomy following ocular photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2003; 136: 830-835.
15. Mruthyunjaya P, Stinnett SS, Toth CA. Change in visual function after macular relocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Ophthalmology 2004; 111: 1715-1724.
16. Gragoudas ES, Adamis AP, Cunningham Jr ET, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805-2816.
17. Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, et al., FOCUS Study Group. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol 2006; 124: 1532-1542.
18. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-1431.
19. Falkner CI, Leitich H, Frommlet F, Bauer P, Binder S. The end of submacular surgery for age-related macular degeneration? A meta-analysis. Graefes Arch Clin Exp Ophthalmol 2007; 245: 490-501.
20. Wong D, Durnian JM. Surgical treatment of age-related macular degeneration: will there be a role in the future? Clin Experiment Ophthalmol 2007; 35: 167-173.
21. Lux A, Llacer H, Heussen FM, Joussen AM. 'Nonresponders' to Bevacizumab (Avastin) therapy of choroidal neovascular lesions. Br J Ophthalmol 2007; 91: 1318-1322.